BioCentury
ARTICLE | Company News

Veracyte sales and marketing update

January 6, 2014 8:00 AM UTC

On Dec. 16, 2013, Veracyte said health insurer Cigna issued a positive coverage policy for Veracyte's Afirma Gene Expression Classifier. The new coverage policy, which is effective immediately, will apply to Cigna's 13 million medical customers, bringing the total of covered individuals to more than 115 million. ...